Efficacy of Ultrasound-guided Greater Auricular Nerve Block in Preventing Postoperative Emergence Agitation in Pediatric Patients Undergoing Microscopic Middle Ear Surgery.
Key facts
- Who runs it
- Fayoum University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 74 people, planned
- Started
- 1 Aug 2025
- Planned end
- 1 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- ultrasound-guided greater auricular nerve block (GANB)
- Record updated
- 27 February 2026
Who can take part
- Age
- 5 years to 14 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age between 5 and 14 years (preschool to early school age group at highest risk for EA)
- ASA physical status I or II
- Scheduled for elective microscopic middle ear surgery under general anesthesia (e.g., tympanoplasty, myringoplasty)
- Ability to comply with FLACC and PAED scoring during postoperative period
- Informed consent obtained from a parent or legal guardian
Who cannot take part
- Known neurological, developmental, or psychiatric disorders (e.g., autism, ADHD, seizure disorder)
- Known hypersensitivity to amide local anesthetics (e.g., lidocaine, bupivacaine)
- Skin infection, hematoma, or trauma at or near the proposed block site
- Inability to assess pain or agitation due to hearing loss, or communication impairment
- Non-elective (emergency) or combined surgeries
- Parental or legal guardian refusal to participate
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 5 and 14 years old?
This trial is currently available in Egypt.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is designed to evaluate the effectiveness of ultrasound-guided greater auricular nerve block (GAN) on the reduction of emergence agitation (EA) occurrence and EA severity in children who are receiving general anesthesia for a microscopic middle ear operation.
The 2 groups in the trial
- group G (GANB group)Treatment being tested
Patients in this group will receive a unilateral ultrasound-guided greater auricular nerve block (GANB) on the operative side, with a 0.5-1.5 mg/kg 0.25% Bupivacaine, immediately after induction of general anesthesia and prior to surgical incision
Treatment: ultrasound-guided greater auricular nerve block (GANB)
- group C (control group)No study treatment, for comparison
Patients in this group will receive no nerve block, to maintain blinding, the ultrasound probe will be applied to the same anatomical region with no needle insertion or injection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy of Ultrasound-guided Greater Auricular Nerve Block in Preventing Postoperative Emergence Agitation in Pediatric Patients Undergoing Microscopic Middle Ear Surgery: A PROSPECTIVE RANDOMIZED DOUBLE- BLINDED CLINICAL TRIAL
- Criteria questions
- Built from NCT07435675, who can take part
- Record updated
- 27 February 2026